Literature DB >> 16282596

Potassium channels, memory T cells, and multiple sclerosis.

Christine Beeton1, K George Chandy.   

Abstract

Multiple sclerosis is a chronic inflammatory autoimmune disease of the central nervous system characterized by demyelination and axonal damage that result in disabling neurological deficits. Here the authors explain the rationale for the use of inhibitors of the Kv1.3 K+ channel in immune cells as a therapy for multiple sclerosis and other autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282596     DOI: 10.1177/1073858405278016

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  50 in total

1.  KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Xueyou Hu; Teresina Laragione; Liang Sun; Shyny Koshy; Karlie R Jones; Iskander I Ismailov; Patricia Yotnda; Frank T Horrigan; Pércio S Gulko; Christine Beeton
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

2.  Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.

Authors:  Philippe Azam; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Stephen Griffey; Heike Wulff
Journal:  J Invest Dermatol       Date:  2007-02-01       Impact factor: 8.551

3.  Kv1.5 association modifies Kv1.3 traffic and membrane localization.

Authors:  Rubén Vicente; Núria Villalonga; Maria Calvo; Artur Escalada; Carles Solsona; Concepció Soler; Michael M Tamkun; Antonio Felipe
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

Review 4.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

5.  KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis.

Authors:  Mark R Tanner; Xueyou Hu; Redwan Huq; Rajeev B Tajhya; Liang Sun; Fatima S Khan; Teresina Laragione; Frank T Horrigan; Pércio S Gulko; Christine Beeton
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

6.  Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis.

Authors:  Lie Di; Shekhar Srivastava; Olga Zhdanova; Yi Ding; Zhai Li; Heike Wulff; Maria Lafaille; Edward Y Skolnik
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

7.  Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques.

Authors:  L E Pereira; F Villinger; H Wulff; A Sankaranarayanan; G Raman; A A Ansari
Journal:  Exp Biol Med (Maywood)       Date:  2007-11

Review 8.  Voltage-gated potassium channels as therapeutic targets.

Authors:  Heike Wulff; Neil A Castle; Luis A Pardo
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694

9.  Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.

Authors:  Manuela B Pucca; Thaís B Bertolini; Felipe A Cerni; Karla C F Bordon; Steve Peigneur; Jan Tytgat; Vânia L Bonato; Eliane C Arantes
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

10.  Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity model.

Authors:  Susumu Ohya; Erina Nakamura; Sayuri Horiba; Hiroaki Kito; Miki Matsui; Hisao Yamamura; Yuji Imaizumi
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.